Xinming Life Science Technology (00474.HK) announced its annual performance, reporting a profit attributable to the owners of HKD 338 million for the year, returning to profitability compared to the same period last year.

According to Zhithong Finance APP, Ximing Life Technology (00474.HK) announced its annual performance for the year ending March 31, 2026, with revenue from continuing operations of HKD 58 million, a year-on-year increase of 16%; profit attributable to shareholders for the year was HKD 338 million, turning from loss to profit compared to the same period last year; earnings per share were HKD 4.54.